471 related articles for article (PubMed ID: 25124496)
1. Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.
Kreusser MM; Lehmann LH; Keranov S; Hoting MO; Oehl U; Kohlhaas M; Reil JC; Neumann K; Schneider MD; Hill JA; Dobrev D; Maack C; Maier LS; Gröne HJ; Katus HA; Olson EN; Backs J
Circulation; 2014 Oct; 130(15):1262-73. PubMed ID: 25124496
[TBL] [Abstract][Full Text] [Related]
2. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
[TBL] [Abstract][Full Text] [Related]
3. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
4. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
[TBL] [Abstract][Full Text] [Related]
5. Inducible cardiomyocyte-specific deletion of CaM kinase II protects from pressure overload-induced heart failure.
Kreusser MM; Lehmann LH; Wolf N; Keranov S; Jungmann A; Gröne HJ; Müller OJ; Katus HA; Backs J
Basic Res Cardiol; 2016 Nov; 111(6):65. PubMed ID: 27683174
[TBL] [Abstract][Full Text] [Related]
6. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
[TBL] [Abstract][Full Text] [Related]
7. Intermedin alleviates pathological cardiac remodeling by upregulating klotho.
Zhang LS; Liu Y; Chen Y; Ren JL; Zhang YR; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
Pharmacol Res; 2020 Sep; 159():104926. PubMed ID: 32502636
[TBL] [Abstract][Full Text] [Related]
8. The combined inhibition of the CaMKIIδ and calcineurin signaling cascade attenuates IGF-IIR-induced cardiac hypertrophy.
Chen CH; Lin JW; Huang CY; Yeh YL; Shen CY; Badrealam KF; Ho TJ; Padma VV; Kuo WW; Huang CY
J Cell Physiol; 2020 Apr; 235(4):3539-3547. PubMed ID: 31584202
[TBL] [Abstract][Full Text] [Related]
9. Caveolae-specific activation loop between CaMKII and L-type Ca
Tonegawa K; Otsuka W; Kumagai S; Matsunami S; Hayamizu N; Tanaka S; Moriwaki K; Obana M; Maeda M; Asahi M; Kiyonari H; Fujio Y; Nakayama H
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H501-H514. PubMed ID: 28039202
[TBL] [Abstract][Full Text] [Related]
10. Early remodeling of perinuclear Ca2+ stores and nucleoplasmic Ca2+ signaling during the development of hypertrophy and heart failure.
Ljubojevic S; Radulovic S; Leitinger G; Sedej S; Sacherer M; Holzer M; Winkler C; Pritz E; Mittler T; Schmidt A; Sereinigg M; Wakula P; Zissimopoulos S; Bisping E; Post H; Marsche G; Bossuyt J; Bers DM; Kockskämper J; Pieske B
Circulation; 2014 Jul; 130(3):244-55. PubMed ID: 24928680
[TBL] [Abstract][Full Text] [Related]
11. CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes.
Helmstadter KG; Ljubojevic-Holzer S; Wood BM; Taheri KD; Sedej S; Erickson JR; Bossuyt J; Bers DM
Basic Res Cardiol; 2021 Feb; 116(1):11. PubMed ID: 33590335
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptor.
Chakraborty A; Pasek DA; Huang TQ; Gomez AC; Yamaguchi N; Anderson ME; Meissner G
PLoS One; 2014; 9(8):e104338. PubMed ID: 25093823
[TBL] [Abstract][Full Text] [Related]
13. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.
Kato T; Sano M; Miyoshi S; Sato T; Hakuno D; Ishida H; Kinoshita-Nakazawa H; Fukuda K; Ogawa S
Circ Res; 2000 Nov; 87(10):937-45. PubMed ID: 11073891
[TBL] [Abstract][Full Text] [Related]
14. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/NFAT and Smad-7.
Li X; Chu G; Zhu F; Zheng Z; Wang X; Zhang G; Wang F
Exp Cell Res; 2020 Jan; 386(1):111716. PubMed ID: 31734152
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin-NFATc regulates type 2 inositol 1,4,5-trisphosphate receptor (InsP3R2) expression during cardiac remodeling.
Sankar N; deTombe PP; Mignery GA
J Biol Chem; 2014 Feb; 289(9):6188-98. PubMed ID: 24415751
[TBL] [Abstract][Full Text] [Related]
16. Imbalance between CaM kinase II and calcineurin activities impairs caffeine-induced calcium release in hypertrophic cardiomyocytes.
Lu YM; Shioda N; Han F; Moriguchi S; Kasahara J; Shirasaki Y; Qin ZH; Fukunaga K
Biochem Pharmacol; 2007 Dec; 74(12):1727-37. PubMed ID: 17888407
[TBL] [Abstract][Full Text] [Related]
17. Genetic deletion of calcium/calmodulin-dependent protein kinase type II delta does not mitigate adverse myocardial remodeling in volume-overloaded hearts.
Mohamed BA; Elkenani M; Jakubiczka-Smorag J; Buchholz E; Koszewa S; Lbik D; Schnelle M; Hasenfuss G; Toischer K
Sci Rep; 2019 Jul; 9(1):9889. PubMed ID: 31285482
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
19. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
20. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
